Difficulties in reaching therapeutic goals for hypertension and dysplipidaemia in patients with type 2 diabetes in general practice

National guidelines recommend strict control of blood pressure (BP) and plasma low-density lipoprotein cholesterol (LDL) in type 2 diabetes (T2DM), aiming at a BP ≤ 130/80 mmHg and an LDL concentration ≤ 2.5 mmol/l. Angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II-receptor blockers...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Danish medical journal 2013-12, Vol.60 (12), p.A4740-A4740
Hauptverfasser:	Knudsen, Søren Tang, Mosbech, Thomas Hammershaimb, Hansen, Birtha, Kønig, Else, Johnsen, Peter Christian, Kamper, Anne-Lise
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Angiotensin Receptor Antagonists - therapeutic use Angiotensin-Converting Enzyme Inhibitors - therapeutic use Antihypertensive Agents - therapeutic use Blood Pressure Cholesterol, LDL - blood Denmark Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Female General Practice Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Hypercholesterolemia - blood Hypercholesterolemia - complications Hypercholesterolemia - drug therapy Hypertension - complications Hypertension - drug therapy Hypertension - physiopathology Hypoglycemic Agents - therapeutic use Hypolipidemic Agents - therapeutic use Male Middle Aged Patient Care Planning Practice Guidelines as Topic Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!